The Ministry of Health said the results of the vaccine were based on an interim analysis of clinical trials launched by the United Arab Emirates in July. Although some details have been provided, the report refers to publicly published information on the effectiveness of the Chinese vaccine, which was developed by the Chinese National Biotech Group (CNPG), a division of Sinoform. The UAE approved lead workers in September. “The analysis did not show any serious safety concerns,” the report added, adding that the “official record” of the vaccine, or how many volunteers were vaccinated or a Govt-19 vaccine, was an important step in combating the global epidemic, whether individual participants experienced any particular side effects. This report does not describe what the official record will be. The report said that clinical trials involve 31,000 volunteers from 125 nationalities in the United Arab Emirates. So far, nearly 100,000 people across the Emirates have been vaccinated as part of a voluntary program, according to CNN, the United Arab Emirates’ top health official. Sheikh Mohammed bin Rashid Al Maktoum, the Vice President and Prime Minister of the United Arab Emirates, was thought to be receiving the jab during the November raids. CNN has approached Sinopharma for more details. China currently has five corona virus candidates from four companies that have reached Phase 3 clinical trials, the last and most important step of testing before regulatory approval is obtained. Within it largely eliminated the spread of the corona virus across borders, Chinese pharmaceutical manufacturers had to look abroad for places to test the effectiveness of their vaccines. Together, they have conducted Phase 3 trials in at least 16 countries. In exchange, many host countries have been promised quick access to successful vaccines – in some cases, technology that knows how to produce them locally. The UAE, along with Sinoform, said it hopes to produce between 75 and 100 million doses next year. In November, Sinoform chairman Liu Jingzhen said dozens of countries had applied to buy the company’s vaccines. He did not name the countries or describe the size of their proposed quantities, but said that CNPG has the potential to produce more than one billion volumes by 2021. “Not only is China politically motivated (and its vaccine diplomacy) Compared to Pfizer and Modernna, most Chinese vaccines do not require freezing temperatures for storage, making transportation and distribution much easier, especially in developing countries where cold storage capacity is not available. Vaccination has begun, while Modernna Jab is still in the final stages of testing in both countries. Stimulates the body – a new technology not used in existing vaccines, but MRNA is susceptible to degradation at room temperature. Store up to 30 days, while the Pfizer vaccine should be stored at an extreme cold temperature of -75˚C (-103). ˚F), and is used within five days of refrigeration at high temperatures. Synoform, meanwhile, uses a long-term approach that has proven effective in other vaccines such as polio and influenza scenarios. Their corona virus vaccines inactivate the whole virus to build up immunity in the body, and should only be stored at a constant refrigerator temperature of 2˚C to 8˚C (36˚F to 46˚F). Other Chinese vaccines in production can be kept at similar temperatures. Reported by CNN’s Beijing Bureau and Nector Gunn in Hong Kong. .
Source